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Abstract. We report that caveolin-1, one of the major
structural protein of caveolae, interacts with TCP-1, a
hetero-oligomeric chaperone complex present in all eu-
karyotic cells that contributes mainly to the folding of
actin and tubulin. The caveolin-TCP-1 interaction entails
the first 32 amino acids of the N-terminal segment of
caveolin. Our data show that caveolin-1 expression is
needed for the induction of TCP-1 actin folding function
in response to insulin stimulation. Caveolin-1 phosphory-
lation at tyrosine residue 14 induces the dissociation of
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caveolin-1 from TCP-1 and activates actin folding. We
show that the mechanism by which caveolin-1 modulates
TCP-1 activity is indirect and involves the cytoskeleton
linker filamin. Filamin is known to bind caveolin-1 and to
function as a negative regulator of insulin-mediated sig-
naling. Our data support the notion that the caveolin-fil-
amin interaction contributes to restore insulin-mediated
phosphorylation of caveolin, thus allowing the release of
active TCP-1.
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Introduction
Caveolae are 50–100-nm invaginated plasma membrane
domains present in non-lymphoid and neuronal cells.
They participate in four main processes, namely, inter-
nalization of pathogens and endocytosis of nutriments
[1–4], cholesterol transport, signal transduction and cell
transformation [1]. Numerous signaling molecules [src
kinases, growth factors, G proteins, phospholipase C-g,
protein kinase-C (PKC) and Ras] have been reported to
interact with caveolin-1, a major protein component of
caveolae and membrane lipid rafts [5], thus suggesting
that these membrane domains play a crucial role in as-
sembling signaling complexes. Caveolin-1 has been shown
to function as a tumor suppressor, and phosphorylation of
caveolin-1 or reduction of its expression level have been
correlated with cell transformation [1, 6]. Caveolin-1 is
an integral membrane protein that forms homo-oligomers
and shows an unusual hairpin-like structure, exposing
both the N and C termini to the cytosol [7]. Functionally,
the N-terminal segment of caveolin-1 is of great impor-
tance and contains an oligomerization site (residues 61–
101) overlapping with a scaffolding domain (residues 82–
101), which binds to diverse signaling molecules [5, 8, 9].
Moreover, caveolin-1 residue Y14 is phosphorylated by
the insulin receptor (IR) in response to insulin stimulation
[10, 11], or by c-Src or c-Abl in response to cell transfor-
mation and during oxidative or hyperosmotic stresses
[11, 12]. Finally, caveolin-1 is expressed as two isoforms
a and b, the later lacking the first 32 N-terminal residues
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due to alternate initiation of the translation of a single
mRNA transcript [13]. The functional difference between
the two isoforms remains, however, unclear [7, 13, 14].
TCP-1 is a hetero-oligomeric, double-torus-shaped mol-
ecular complex composed of eight different highly con-
served polypeptides. It appears as 12–16-nm particles
[15, 16], and is abundant in the eukaryotic cytosol. TCP-
1 is ubiquitously expressed in all eukaryotic organisms
and all mammalian cell types thus far investigated, and is
essential for cell survival [17]. TCP-1 assists in protein
folding in the cytosol in a process that is Mg dependent
and requires ATP hydrolysis [18–20]. In contrast to
GroEL, which assists in the folding of a large variety of
proteins, TCP-1 folds mainly actin and tubulin and only a
limited number of other cytosolic proteins [16, 19, 20].
Although GroEL also binds actin and tubulin, these two
proteins undergo their final stage of folding only when
associated to TCP-1. TCP-1 identifies actin and tubulin
via specific subunits of its apical region around the cen-
tral channel domain and assists actin in reaching its ma-
ture conformation by folding its nucleotide binding site
[21–23].
In this report, we provide evidence for a specific interac-
tion of TCP-1 and the N-terminal region of caveolin-1 a,
which hampers the actin folding function of the se-
questered chaperone molecules. The phosphorylation of
caveolin residue Y14, which has been reported to be in-
volved in several caveolin-mediated signaling pathways
including insulin cell activation [10–12], blocks that in-
teraction and restores the function of TCP-1. The fact that
the folding activity of TCP-1 is also impaired in cells ex-
pressing caveolin Y14F mutant is suggestive for an indi-
rect effect of caveolin on the activity of TCP-1. Using in-
sulin as a cell activation effector, we show that the spe-
cific interaction of TCP-1 with caveolin-1 prevents the
caveolin-1 from binding and inactivating the cytoskeleton
linker filamin known to inhibit insulin-mediated signals
transduced by the IR [26, 27].
Experimental procedures
Materials
Chemicals were purchased from Sigma (Buchs, Switzer-
land), except for protein A-Sepharose beads, CNBr-ac-
tivated Sepharose 4B, and dry polyacrylamide gel strips
(pH 3–10; ImmobilineTM DryStrip) from Amersham Bio-
sciences (Uppsala, Sweden), fugene 6 from Roche Applied
Science (Rotenkreuz, Switzerland), lipofectAMINE2000
from Invitrogen (Frederick, MA), and porcine sequenc-
ing grade trypsin from Promega (Madison, WI).
Polyclonal rabbit anti-caveolin antibody (Transduction
Laboratories, Lexington, KY), polyclonal rabbit anti-
TCP1b and monoclonal rat anti-TCP1a (CTA-191) anti-
bodies (StressGen Biotechnologies Corp., Victoria, BC,
Canada) were used for immunodetection and immuno-
precipitation, respectively. Monoclonal mouse anti-phos-
photyrosine (4G10) and polyclonal anti-insulin receptor
b subunit antibodies were from Upstate Biotechnology
(Lake Placid, NY). Monoclonal antibody (clone 83–14) to
the anti-IR (Biosource International, Nivelles, Belgium)
was used for immunoprecipitation. Horseradish peroxi-
dase-conjugated goat anti-rabbit IgG and anti-mouse IgG
were from Santa Cruz Biotechnology (Santa Cruz, CA).
Mouse anti-human filamin antibody (MAB 1680) was
from Chemicon International (Temecula, CA).
Methods
Plasmid, cell culture, cell treatment and transient
transfections. HT29 cells were cultured in RPMI 1640
medium supplemented with 10% fetal calf serum, 5 mg/
ml penicillin and 5 mg/ml streptomycin (GIBCO-BRL
Life Technologies Inc., Paisley, UK). HuH7, M2 and A7
cell lines were grown as described previously [24, 25].
The plasmids placIOP-cav-1 and placIOP-mock that allow,
respectively, isopropyl-b-D-thiogalactopyranoside (IPTG)-
inducible expression of caveolin-1 or the corresponding
mock construct were used for cell transfection as previ-
ously described [6]. The Y14 to F mutation in placIOP-cav-
1 was introduced by PCR using the QuikChange site di-
rected mutagenesis kit from Stratagene (Gebouw, CA).
Dog caveolin a and b were inserted after PCR and all in-
serts checked by sequencing.
HuH7 cells were transiently transfected with caveolin a-
or b-encoding plasmids using fugene 6. M2 and A7 cells
were transfected by calcium phosphate coprecipitation as
described previously [26]. Caveolin expression levels in
transfected HuH, M2 and A7 cells were comparable to the
physiological expression of caveolin in Swiss mouse 3T3
fibroblasts. However, overexpression of caveolin was ob-
tained by IPTG induction at high concentration. ATP/
MgCl2 were both added to the cells at 4 mM for 15 min at
37 °C. M2 and A7 cells were stimulated with insulin as
previously described [25], and HuH7 cells were treated
with deoxyglucose or insulin at 1 U/ml 2 days after trans-
fection.
Synthetic peptides and affinity chromatography. Cave-
olin-derived peptides (Fig. 1a) were synthesized with an
automated solid-phase synthesizer with Fmoc chemistry,
purified by reverse-phase HPLC and characterized by
mass spectrometry (MS) and amino acid analysis. Pep-
tides were coupled to CNBr-activated Sepharose 4B fol-
lowing the instructions of the supplier.
Fifteen dishes (15 cm in diameter) of HT29 cells were
lysed for 5 h on ice in 30 ml 20 mM Tris pH 8.0 contain-
ing 1% Brij 78, and the lysate was clarified by centrifu-
gation at 10 000 g for 10 min. The supernatant was ap-
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plied overnight at 4 °C to columns containing peptide-de-
rivatized Sepharose. Following extensive washing with
lysis buffer supplemented with 0.4 M NaCl, the columns
were eluted with 0.1 M glycine, pH 2.4. and the proteins
precipitated with chloroform/methanol.
2D gel electrophoresis and MS identification of pro-
teins. 2D gel electrophoresis was performed as described
[27], with the following modification in the first dimen-
sion of the gel: the precipitated proteins were solubilized
in 40 mM Tris base containing 7 M urea and 2 M thio-
urea, 4% CHAPS, 1% Brij 78, 0.001% bromophenol blue
and 0.8% resolyte 4–8, 18 mM DTT and 2 mM tributyl-
phosphine. The 2D gels were stained with colloidal silver
[28]. The protein spots were excised from the gel, cleaved
with trypsin [29] and the generated peptides were ana-
lyzed by capillary liquid chromatography tandem mass
spectrometry (LC-MS/MS) using a Magic C18 100 mm
¥10 cm HPLC column (Spectronex, Switzerland) con-
nected on line to an ion trap Finnigan DecaXP (Thermo-
Finnigan, CA). The eluting peptides were ionized by elec-
trospray ionization, and the peptide ions detected were
automatically selected and fragmented in the ion trap. In-
dividual MS/MS spectra, containing sequence informa-
tion for a single peptide, were compared with the program
TurboSequest [30] against the human subset of the pro-
tein sequence database Swiss-Prot 40.36. This resulted in
the identification of the peptide and, by association, the
protein in the spot.
Immunoprecipitation, immunoblotting and sucrose
density gradient. Cells were lysed for 4 h on ice in
20 mM Tris pH 8.0 containing 1% Brij 78 and protease
inhibitors (9.6 mg/ml benzamidine hydrochloride, 0.9 mg/
ml leupeptin and 1.9 mg/ml antipain). An equal amount of
protein lysate was immunoprecipitated and analyzed by
immunoblotting as described previously [31]. Quantita-
tion of the chemiluminescent signals were performed
with ImageJ 1.34s quantification software (NIH, USA).
Caveolin-1-enriched fractions were obtained by isolation
on sucrose density gradient following solubilization in
Triton X-100 as described [7].
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Figure 1. Proteins interacting with the N- and C-terminal peptides of caveolin-1. (a) N- and C-terminal peptides derived from caveolin-1.
(b) Low-density detergent insoluble microdomains from caveolin positive Swiss mouse NIH 3T3 cells were isolated by sucrose density gra-
dient. Proteins were resolved by 2D SDS-PAGE using a pH gradient from 3 to 10 in denaturing buffer supplemented either CHAPS or
CHAPS/Brij 78 mixed micelles for protein solubilization in the first dimension. Recovery and focalization of caveolin were assessed by
Western blotting using caveolin-specific antibodies. (c) HT29 cell lysates were passed through N- and C-terminal peptide affinity columns
and the eluates were subjected to 2D SDS-PAGE using a pH gradient from 3 to 10 in the first dimension and 12% polyacrylamide gel in
the second dimension. The proteins were revealed by silver staining and the right panel shows a blow-up of the N-terminal peptide eluates.
Comparable results were obtained in two independent experiments.
DNase I-inhibition assay. Following two washes with
PBS, the cells were lysed for 4 h on ice in 20 mM Tris pH
8.0 containing 0.3% Triton X-100 and protease inhibitors
(45 mg/ml benzamidine hydrochloride, 5 mg/ml leupeptin
and 10 mg/ml antipain). The lysate was clarified by cen-
trifugation for 5 min at 10 000 g. The DNase I-inhibition
assay was performed as described previously [32, 33] us-
ing 2 ml substrate solution containing 0.04 mg/ml DNA
and 10 U DNase I. The inhibition was measured by
adding 25 mg protein of cell lysate to the substrate solu-
tion for 2 min at 26 °C and changes in OD at 260 nm were
measured. Dissociation of pre-existing F actin to G actin
in vitro requires thermal or chemical unfolding of actin
[32, 33]. Therefore, in a mixture of filamentous and mon-
omeric actin present in a cell extract, only the monomeric
form will inhibit DNase I [32, 33].
Results
The N-terminal segment of caveolin-1 a interacts with
TCP-1
Peptide derived from the N terminus of caveolin-1 in-
teracts with TCP-1. To examine the structural and func-
tional binding properties of caveolin-1 a, we used a pep-
tide corresponding to the first 32 N-terminal residues of
caveolin-1 a and, as a control, a peptide comprising the
last 23 C-terminal residues of caveolin-1 (Fig. 1a). N-
and C-terminal synthetic peptides were covalently at-
tached to Sepharose beads and used for affinity chro-
matography with HT29 cell extracts. Eluted proteins
were separated by 2D SDS-PAGE. Due to their resistance
to non-ionic detergents, solubilization and recovery of
membrane proteins from lipid rafts or caveolae after iso-
electric focusing is often of very low efficiency. Good re-
covery and solubilization of caveolin (Fig. 1b) and of
other raft resident proteins such as Lck, Fyn and Thy-1
(data not shown) were only obtained when CHAPS was
combined with 1% Brij 78 (see Methods section).
The HT29 cell line was chosen because, as most human
colon carcinoma cell lines, it expresses caveolin-1 at very
low levels, thus avoiding competition with the immobi-
lized caveolin peptide. A limited number of proteins were
specifically eluted from both N- and C-terminal peptide
affinity chromatography columns (Fig. 1c). Following
trypsin digestion, the resulting peptide fragments were
separated and analyzed by LC-MS/MS, and proteins from
spots 1, 2, 3 and 5 were identified using the sequence in-
formation of the peptide fragments obtained by MS/MS
(Fig. 2). Spots 1 and 2 were found in both preparations,
although higher amounts were eluted from the N-terminal
peptide column. They were shown to contain actin and
the mitochondrial ATP synthase beta chain, respectively
(Figs 1c and 2). By contrast, spots 3, 4, and 5 were exclu-
sively present in the eluate of the N-terminal peptide
affinity column. No protein could be identified in spot 4
and the other detectable spots due to an insufficient
amount of material. Unexpected was the identification of
spots 3 and 5 as TCP-1 subunits q and b, respectively
(Figs 1c and 2). Indeed caveolin has not been reported as
being a substrate of the chaperone complex TCP-1. More-
over, using a protein blast search, we did not find any se-
quence homology between the N-terminal segment of
caveolin-1 a, or truncated portions of this segment, and
any other protein of the uniprot database, suggesting that
this interaction might be unique. Finally, among the di-
versity of proteins interacting with caveolin [5, 9], a com-
parable association with a molecular chaperone complex
has been previously demonstrated with HSP56, cyclo-
philin 40 and cyclophilin A. Although the complex also
involves annexin II, the precise site of interaction remains
unknown. The function of this caveolin-chaperone com-
plex is the transport of cholesteryl ester from caveolae
through the cytosol to an internal membrane [34, 35].
Caveolin-1 interacts with TCP-1 in cells. To determine
whether caveolin interacts with TCP-1 in cells, we trans-
fected caveolin-1 a or b in human hepatoma HuH or hu-
man melanocyte A7 cells that express very low levels of
caveolin-1 and 2 [24]. The amount of caveolin expressed
in transfected cells was physiological and comparable to
endogenous expression of caveolin in Swiss mouse 3T3
cells (data not shown). The level of association of cave-
olin-1 a to TCP-1 was determined as the ratio between
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Figure 2. The N-terminal segment of caveolin-1 interacts specifically with TCP-1. The protein spots were excised from the 2D gels, di-
gested with trypsin and extracted peptides were separated by capillary LC and sequenced by MS/MS, gray boxes show the peptides for
which the sequences were obtained by MS/MS. The proteins were identified with the program TurboSquest searching the Swiss-Prot 40.36
database; their primary accession number is indicated in parentheses.
the amount of caveolin-1 a co-precipitated with anti-
TCP-1 antibodies and the amount of caveolin-1 a present
in the lysate. Comparison of such quantitations obtained
for caveolin-1 a and b indicated that the latter isoform is
only marginally associated with TCP-1 since its co-pre-
cipitation was always 10 fold lower than the one observed
with the a isoform (Fig. 3a). These data confirm the pre-
dominant role of the 32 N-terminal residues of caveolin-
1 in the interaction with TCP-1, and yet suggests an ad-
ditional minor site of interaction in caveolin-1 b. In ad-
dition, the interaction was stabilized by Mg and Mn
cations and disrupted by chelation of divalent cations
with EDTA (Fig. 3b). Finally, TCP-1 immunoprecipitates
did not contain caspase 3 nor transferrin receptor, al-
though these proteins were both present in large amount
in the cell lysates (data not shown).
To confirm that caveolin interacts with TCP-1 in intact
cells, we examined the effect of this interaction on TCP-
1 actin folding function. Since caveolin-1 is enriched in
caveolae which contain tyrosine kinases and various
growth factor receptors (including IR), we stimulated
HUH cells with serum, insulin or epidermal growth fac-
tor (EGF) that induce caveolin phosphorylation to a vari-
able extent [10, 11]. We measured the impact of these ef-
fectors on TCP-1 actin folding activity in the presence or
absence of caveolin expression. TCP-1 assists actin in
reaching its mature conformation by folding the nu-
cleotide binding site of monomeric G actin, which in turn
can bind DNase-1 with affinities in the nanomolar range
and thus inhibits its endonuclease activity in vitro [22, 32,
33]. Determination of DNase-1 inhibition in cell extracts
therefore enables the measurement of monomeric G actin
concentration and allows the actin folding activity of
TCP-1 in cells to be assessed [33]. Increase in DNase-1
inhibition was observed in caveolin transfected HuH
cells, but not in mock transfected cells, upon insulin, EGF
or serum stimulation. Statistical evaluation of these re-
sults by paired two-tail t-tests, however, revealed that only
insulin can be considered as inducing a significant in-
crease of DNase-1 inhibition (p < 0.05), whereas the ef-
fect of EGF remains at the lower limit of statistical sig-
nificance, and the data obtained with the serum cannot at
that point be considered as significant. In addition, the
differences between untreated or treated non-transfected
cells were not significant (0.2 < p < 0.5). Deoxyglucose
was used as a control to block TCP-1 activity (Fig. 4).
These data show that upon insulin stimulation caveolin
affects TCP-1 actin folding function in intact cells. Fur-
thermore, the absence of a significant increase in DNase-
1 inhibition in mock-transfected cells upon insulin stim-
ulation (p < 0.5) suggests that the mechanism by which
caveolin modulates TCP-1 activity is indirect.
Insulin-mediated phosphorylation of caveolin on Y14
induces the dissociation of the caveolin-TCP-1 com-
plex and promotes TCP-1 folding activity. To under-
stand the mechanism by which caveolin modulates TCP-
1 actin folding activity, we investigated how insulin-me-
diated cell activation increases TCP-1 actin folding in
caveolin-expressing cells (Fig. 4). Insulin has been re-
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Figure 3. TCP-1 associates with caveolin-1 in cells. (a) HuH cells untransfected (-) or transfected with caveolin-1 a or b were lysed, and
the total lysates or immunoprecipitates with anti-TCP-1a antibodies were resolved on SDS-PAGE (12% reducing) and analyzed by West-
ern immunoblotting (ib) with antibodies specific for TCP-1 and caveolin. Caveolin a or b lysates and immunoprecipitates shown corre-
spond to the same amount of protein. (b) TCP-1 was immunoprecipitated from HuH cells transfected with caveolin-1 a in the presence of
EDTA or divalent cations and the immunoprecipitates analyzed as described in (a). Shown is one out of three independent experiments.
Figure 4. Caveolin expression modulates TCP-1 actin folding ac-
tivity upon cell stimulation. HuH cells untransfected or transfected
with caveolin were stimulated with insulin, EGF or serum for 5 min
or pretreated with deoxyglucose for 1 h at 37 °C, lysed and the con-
tent of monomeric G actin in the whole cell lysate determined by
DNase-1 inhibition assay (see Methods section). Shown are the
mean and standard deviation of three independent experiments.
ported to induce caveolin phosphorylation [12] primarily
at residue Y14, a reaction which is likely to result directly
from the engagement of IR [10]. To determine whether
the insulin-mediated phosphorylation of the N-terminal
region of caveolin affects its association with TCP-1,
HuH cells transfected with caveolin a were stimulated
with insulin. After various periods of time up to 30 min,
the interaction between caveolin and TCP-1 was analyzed
by immunoprecipitation. Insulin treatment caused transient
phosphorylation of caveolin, with an optimum reached
after 5 min of stimulation (Fig. 5a). The maximal phos-
phorylation of caveolin correlated with a minimal bind-
ing to TCP-1 (Fig. 5b), suggesting that the phosphoryl-
ation of caveolin inhibits TCP-1 binding (Fig. 5c).
We then examined the role of caveolin phosphorylation
on the actin folding activity of TCP-1. To this end, we
measured the DNase-1 inhibition effect in HuH caveolin
transfectants upon insulin stimulation. A maximal inhibi-
tion was detected in cell extracts after 5 min of stimula-
tion (Fig. 5c), which corresponds to the maximum of
caveolin phosphorylation (Fig. 5a). A control experiment
performed with mock-transfected cells showed no signif-
icant effect of insulin treatment.
In addition, we generated a caveolin mutant in which the
phosphorylation site at Y14 was replaced by a phenylala-
nine. Wild-type and mutant caveolin expression were com-
parable in both HuH and A7 caveolin-transfected cells
(data not shown). Measurement of DNase-1 inhibition
showed that wild-type caveolin but not the Y14F mutant
induced TCP-1 folding activity in response to insulin
stimulation (Fig. 5d). These results demonstrate that
caveolin phosphorylation on residue Y14 is required for
insulin-induced activation of TCP-1 and that caveolin is
necessary to promote the TCP-1 folding activity.
Caveolin-TCP-1 interaction acts as a competitor for
caveolin-filamin interaction and thus restores insulin
signaling. To further understand the complex role of cave-
olin in the control of TCP-1 biological activity, we explored
the possibility that caveolin might interfere with mecha-
nisms regulating insulin-mediated cell activation. This was
based on the observation that the actin-cross-linking pro-
tein filamin interacts with the IR, thereby inducing a deac-
tivation of insulin-mediated signaling events [25]
Since caveolin-1 also binds filamin [36], we hypothe-
sized that this interaction could interfere with the IR-fil-
amin association, and thus restore insulin-mediated sig-
naling and activation of TCP-1.
To test this hypothesis, A7 filamin-expressing cells were
transfected with caveolin-1 a and the interaction between
IR and filamin analyzed by co-immunoprecipitation. In-
deed, expression of caveolin impaired IR-filamin interac-
tion (Fig. 6a) by 45–50% as determined by the quantita-
tion of the relative intensity of ECL signals (see Methods
section). The impact of the competition between filamin
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Figure 5. Insulin-mediated phosphorylation of caveolin induces
caveolin-TCP-1 complex dissociation and activation of actin fold-
ing. Kinetic of caveolin phosphorylation (a) and caveolin associ-
ation with TCP-1 (b) were examined upon addition of insulin to
caveolin-transfected HuH cells. Cell lysates were immunoprecip-
itated with anti-caveolin- (a) or anti-TCP-1- (b) specific antibod-
ies and the immunoprecipitates resolved by SDS-PAGE and ana-
lyzed by Western blotting using anti-phosphotyrosine (pY), anti-
caveolin or anti-TCP-1b antibodies. (c) Aliquots of the same HuH
cell lysates were used to determine their content of monomeric G
actin in by DNase-1 inhibition assay. (d) HuH cells transfected
with either wild-type or Y14F mutant caveolin were stimulated
with insulin for 5 min, lysed and the content of monomeric G
actin determined by DNase-1 inhibition assay. In (c) and (d) the
mean and standard deviation of three independent experiments are
shown.
binding to caveolin or the IR on TCP-1 activation was then
assessed using A7 and the derived filamin-deficient M2
cell lines. Both cell types were transfected with a plasmid
encoding caveolin-1 a under the control of an IPTG-in-
ducible promoter, and the activity of TCP-1 was deter-
mined by the measure of DNase-1 inhibition following
insulin stimulation.
In A7 cells, in the absence of caveolin expression, no
change in DNase-1 inhibition was detected upon 10 min
of insulin treatment (Fig. 6b). By contrast, following
induction of caveolin expression with graduated doses of
IPTG, a significant increase in DNase-1 inhibition was
observed at 100 mM IPTG, corresponding probably to
the optimal level of caveolin-1 expression inducing the
strongest effect. Lower or higher expression levels of
caveolin failed to induce any detectable change in
DNase-1 inhibition upon insulin stimulation (Fig. 6b).
Thus in A7 cells, like in HuH cells, caveolin regulates its
folding activity via its association with TCP-1 (Fig. 5c).
By contrast to A7 cells, when M2 filamin-deficient cells
were used, insulin induced a stronger DNase-1 inhibition
in the absence of caveolin expression (Fig. 6b). This con-
firms the selective impairment in insulin signaling by fil-
amin [25]. Importantly, in both A7 and M2 cells express-
ing levels of caveolin higher than that obtained with
100 mM and 1000 mM IPTG, respectively, insulin stimu-
lation failed to induce DNase-1 inhibition, indicating that
caveolin can inhibit TCP-1 activation (Fig. 6b). Further
evidence for the direct inhibitory effect of caveolin on
TCP-1 actin folding function was provided by the exper-
iment using the caveolin mutant Y14F, which showed im-
paired activation of TCP-1 upon insulin stimulation
(Fig. 5d). This effect was independent of the level of cav-
eolin expression (data not shown). In addition, at low ex-
pression levels (up to 10 mM IPTG), caveolin can restore
insulin-mediated activation of TCP-1 in A7 cells (Fig. 6a)
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Figure 6. Role of caveolin in insulin-induced activation of TCP-1.
(a) Interaction of the IR with filamin in A7 cells transfected or not
with caveolin. The IR was immunoprecipitated with specific anti-
bodies and the immunoprecipitates resolved by SDS-PAGE fol-
lowed by Western blotting using anti-filamin- or anti-IR-specific
antibodies. Equal amounts of protein cell lysates were examined by
immunoblotting using anti-caveolin-specific antibodies (top pan-
els). (b) Insulin-mediated folding of G actin in filamin-positive
(A7) and filamin-negative (M2) cells expressing increasing con-
centrations of caveolin. Shown is one representative out of three in-
dependent experiments (a and b) at optimal time of DNase-1 inhi-
bition, i.e., 10 min after insulin stimulation (b).
Figure 7. Mechanism of caveolin regulation of TCP-1 activity. Filamin, by interacting with the IR, inhibits insulin-mediated signaling. At
low expression level, caveolin does not compete efficiently for this interaction but, by associating with TCP-1, inhibits its actin folding
function (left panel). At higher expression level, caveolin sequesters filamin from the IR and allows insulin-mediated phosphorylation of
caveolin at Y14 and the release of the functionally immobilized TCP-1 (right panel).
by competing for the IR-filamin interaction (Fig. 6b). Taken
together these results indicate that caveolin-1 can func-
tion as a direct inhibitor of TCP-1 folding activity and as
an indirect activator of TCP-1 by competing for the fil-
amin-IR interaction.
Discussion
In the present study, we have shown that caveolin binds the
chaperone complex TCP-1 and thus contributes to the
regulation of its protein folding function. The N-terminal
region of caveolin-1 a is crucial for that interaction as ev-
idenced by the specific binding of TCP-1 to a 32-amino
acid synthetic peptide corresponding to the N terminus of
the protein. Moreover, TCP-1 can be co-immunoprecipi-
tated with native caveolin-1 a, whereas only a weak in-
teraction was observed between the chaperone complex
and caveolin-1 b, an isoform of caveolin-1 that lacks the
32 N-terminal residues.
Several other proteins were consistently found in associ-
ation with the caveolin-1 N-terminal peptide, among which
ATP synthase and actin could be identified. The presence
of actin is consistent with its specific binding to TCP-1
under the mild dispersing conditions used in our experi-
ments. Indeed, the actin-TCP-1 interaction is highly re-
sistant to the disruption in mixed micelles of ionic and
non-ionic detergents that cause complete disruption of
the TCP-1 hexadecamer into its constituent subunits [37].
2D electrophoresis revealed a number of spots corre-
sponding to the various subunits of TCP-1 [38, 39],
among which the subunits b and q were in a sufficient
amount to allow their identification by MS. Our data
show that TCP-1 interacts with the N-terminal segment of
caveolin, but due to the fact that under the experimental
conditions used, TCP-1 dissociates partially into its con-
stituent subunits, it remains difficult to evaluate the pro-
portion of TCP-1 complexes associated with caveolin.
Our data are consistent with a quantitative proteomic
analysis demonstrating that both caveolin and TCP-1 par-
titioned in glycolipid-enriched membrane microdomains
[40]. Considering that the cytosolic chaperone complex
TCP-1 is expected to partition in the detergent soluble
fractions, its localization in rafts might result from its as-
sociation with caveolae cytosolic organelles.
Using a DNase I-inhibition assay, which measures the
amount of folded actin [32, 33], we provide evidence that
caveolin exerts two competing effects on TCP-1 actin
folding function. Caveolin, by binding directly to TCP-1,
inhibits the chaperone actin folding function as observed
in filamin-deficient cells expressing large amounts of
caveolin (Fig. 6b). Further evidence for a direct inhibition
of TCP-1 by caveolin were obtained by the observation
that the Y14F caveolin mutant does not induce TCP-1 ac-
tivation nor dissociation from TCP-1 upon insulin stimu-
lation (Fig. 5). These data demonstrate that the specific
phosphorylation of this residue controls both the cave-
olin-TCP-1 interaction and the chaperone folding func-
tion (Fig. 7).
By preventing the actin cross-linking protein filamin
to bind to the IR, caveolin restores insulin-mediated sig-
naling and activates TCP-1 actin folding function
(Fig. 6b). The fragment of filamin spanning repeats 22,
23 and the hinge region are involved in the interaction
with both caveolin and the IR [25, 36]. Caveolin interacts
with TCP-1 mainly through its first 32 N-terminal
residues and with filamin via residues 32–101 (Figs 1 and
2). In addition, a possible negative influence of the first
32 N-terminal residues on the strength of this later inter-
action has been described [25]. The filamin-caveolin
complex sequesters filamin from the IR, and thus pre-
vents the phosphorylation of caveolin associated with fil-
amin (Fig. 6, right panel). This complex, by sequestering
filamin from the IR, restores insulin signaling through
the IR-caveolin-TCP-1 complex. Consequently, insulin
mediates phosphorylation of caveolin at Y14, which in
turn induces the dissociation of caveolin from TCP-1 and
the activation of the chaperone (Fig. 6, right panel). Thus,
low expression of caveolin in filamin-expressing cells
may not be sufficient to compete for filamin-IR interac-
tion (Fig. 6. from left to right panel). In contrast, in fil-
amin-deficient cells, such a low level of caveolin is suffi-
cient to inhibit TCP-1 activity, and to override insulin-
mediated activation of TCP-1. Consequently, at a high
level of expression of caveolin, the formation of the com-
plex with TCP-1 prevails over its insulin-mediated disso-
ciation. This is most likely due to the fact that insulin-me-
diated phosphorylation of caveolin is transient (Fig. 3a).
Moreover, by forming such a complex, the chaperone
TCP-1 could modulate the conformation and the func-
tions of caveolin. In fact, a key role of caveolin is to act as
a negative regulator of signaling molecules, a function
that was initially attributed to the scaffolding domain [5,
9] and more recently to a specific active conformation of
the protein [41].
Our data show that a functional consequence of caveolin-
TCP-1 interaction is the regulation of the insulin-medi-
ated mitogenic pathway. Similar effects of TCP-1 actin
folding function was obtained upon EGF or serum treat-
ment (Fig. 4), indicating that mediators of caveolin phos-
phorylation release the functionally sequestered chaper-
one. However, it remains to be determined whether the
mechanism identified for insulin stimulation is similar
for EGF and serum treatment, and represents a more gen-
eral mechanism of caveolin regulatory function.
An additional important function of caveolin-TCP-1 in-
teraction may be to regulate the interaction of caveolae
with the cortical actin cytoskeleton. Caveolae tend to col-
lect in the actin-rich region of the cell membrane and con-
tain the actin and caveolin binding protein filamin. There-
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fore, by regulating actin folding function of TCP-1, cave-
olin may control the vesicular traffic of caveolae between
the cell surface and intracellular organelles.
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